ATE303814T1 - Zusammensetzung mit steoridisher östrogen wirkung ohne steigerung des brustkrebsrisikos - Google Patents

Zusammensetzung mit steoridisher östrogen wirkung ohne steigerung des brustkrebsrisikos

Info

Publication number
ATE303814T1
ATE303814T1 AT00945665T AT00945665T ATE303814T1 AT E303814 T1 ATE303814 T1 AT E303814T1 AT 00945665 T AT00945665 T AT 00945665T AT 00945665 T AT00945665 T AT 00945665T AT E303814 T1 ATE303814 T1 AT E303814T1
Authority
AT
Austria
Prior art keywords
breast cancer
estrogen
composition
risk
steoridish
Prior art date
Application number
AT00945665T
Other languages
English (en)
Inventor
Nils Bruenner
Mogens Spang-Thomsen
Original Assignee
Uinv Kobenhavns
Rigshospitalet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8100258&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE303814(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Uinv Kobenhavns, Rigshospitalet filed Critical Uinv Kobenhavns
Application granted granted Critical
Publication of ATE303814T1 publication Critical patent/ATE303814T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00945665T 1999-07-15 2000-07-17 Zusammensetzung mit steoridisher östrogen wirkung ohne steigerung des brustkrebsrisikos ATE303814T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901034 1999-07-15
PCT/DK2000/000406 WO2001005415A2 (en) 1999-07-15 2000-07-17 Composition having steroidal estrogen effect without increasing the risk of breast cancer

Publications (1)

Publication Number Publication Date
ATE303814T1 true ATE303814T1 (de) 2005-09-15

Family

ID=8100258

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00945665T ATE303814T1 (de) 1999-07-15 2000-07-17 Zusammensetzung mit steoridisher östrogen wirkung ohne steigerung des brustkrebsrisikos

Country Status (7)

Country Link
EP (1) EP1200107B1 (de)
AT (1) ATE303814T1 (de)
AU (1) AU771581B2 (de)
DE (1) DE60022517T2 (de)
DK (1) DK1200107T3 (de)
ES (1) ES2249278T3 (de)
WO (1) WO2001005415A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2300783T3 (es) * 2003-07-01 2008-06-16 Max Zeller Sohne Ag Procedimiento de extraccion vegetal y extracto.
KR20090029237A (ko) 2006-06-02 2009-03-20 피어 트리 파머슈티칼스 인코포레이티드 위축성 질염을 치료하는 방법
AU2013285492B2 (en) 2012-07-03 2015-11-12 Max Zeller Soehne Ag Novel pharmacological use of Cimicifuga extract
RU2680603C1 (ru) * 2018-11-08 2019-02-25 Ильясов Шамиль Сионович Применение 3-о-сульфамата-16,16-диметил-d-гомоэквиленина для лечения онкологических заболеваний
IT201900000343A1 (it) 2019-01-10 2020-07-10 Herbal E Antioxidant Derivatives S R L Ed In Forma Abbreviata H&Ad S R L Composizioni per il trattamento della menopausa, osteopenia e osteoporosi, disturbi metabolici e vascolari legati al climaterio

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19652183C1 (de) * 1996-12-14 1998-02-12 Schaper & Bruemmer Gmbh Verwendung eines Extraktes aus Cimicifuga racemosa

Also Published As

Publication number Publication date
DE60022517D1 (de) 2005-10-13
EP1200107B1 (de) 2005-09-07
AU771581B2 (en) 2004-03-25
AU5966900A (en) 2001-02-05
DK1200107T3 (da) 2006-01-16
DE60022517T2 (de) 2006-08-03
WO2001005415A2 (en) 2001-01-25
EP1200107A2 (de) 2002-05-02
ES2249278T3 (es) 2006-04-01
WO2001005415A3 (en) 2001-05-25

Similar Documents

Publication Publication Date Title
Luo et al. Lycium barbarum polysaccharides induce apoptosis in human prostate cancer cells and inhibits prostate cancer growth in a xenograft mouse model of human prostate cancer
Hsieh et al. Dioscin-induced autophagy mitigates cell apoptosis through modulation of PI3K/Akt and ERK and JNK signaling pathways in human lung cancer cell lines
Mokashi et al. Flavonoids from Enicostema littorale blume enhances glucose uptake of cells in insulin resistant human liver cancer (HepG2) cell line via IRS-1/PI3K/Akt pathway
Boisvert et al. Hair growth-promoting effect of Geranium sibiricum extract in human dermal papilla cells and C57BL/6 mice
Nassar et al. Chemical constituents and anti‐ulcerogenic potential of the scales of Cynara scolymus (artichoke) heads
Zugic et al. Evaluation of anticancer and antioxidant activity of a commercially available CO2 supercritical extract of old man’s beard (Usnea barbata)
Joshi et al. Hepatoprotective potential of antioxidant potent fraction from Urtica dioica Linn.(whole plant) in CCl4 challenged rats
Wang et al. Solanum nigrum L. polyphenolic extract inhibits hepatocarcinoma cell growth by inducing G2/M phase arrest and apoptosis
EA200100872A1 (ru) Композиция валдекоксиба
Lee et al. Sanguinarine induces apoptosis of human oral squamous cell carcinoma KB cells via inactivation of the PI3K/Akt signaling pathway
Mathema et al. Growth inhibitory effect of β‐eudesmol on cholangiocarcinoma cells and its potential suppressive effect on heme oxygenase‐1 production, STAT 1/3 activation, and NF‐κB downregulation
Strzemski et al. In vitro antiproliferative activity of extracts of Carlina acaulis subsp. caulescens and Carlina acanthifolia subsp. utzka
Wang et al. Chemopreventive effects of atractylenolide II on mammary tumorigenesis via activating Nrf2-ARE pathway
Li et al. Zerumbone‐induced reactive oxygen species‐mediated oxidative stress re‐sensitizes breast cancer cells to paclitaxel
Park et al. Inhibition of matrix metalloproteinase activities and tightening of tight junctions by diallyl disulfide in AGS human gastric carcinoma cells
Koriem et al. Protective effect of Cupressus sempervirens extract against indomethacin-induced gastric ulcer in rats
Kim et al. Amentoflavone, active compound of Selaginella tamariscina, inhibits in vitro and in vivo TGF-β-induced metastasis of human cancer cells
Martino et al. Polyphenol‐rich fraction from Larrea divaricata and its main flavonoid quercetin‐3‐methyl ether induce apoptosis in lymphoma cells through nitrosative stress
ATE237334T1 (de) Neue pharmazeutische zusammensetzungen von steroid-nitratester zur verwendung als enzündungshemmer
Liu et al. Ginsenoside C‐Mx isolated from notoginseng stem‐leaf ginsenosides attenuates ultraviolet B‐mediated photoaging in human dermal fibroblasts
Ji et al. Amino acid sequence identification of goji berry cyclic peptides and anticervical carcinoma activity detection
Karimian et al. The chemopreventive effect of Tanacetum polycephalum against LA7-induced breast cancer in rats and the apoptotic effect of a cytotoxic sesquiterpene lactone in MCF7 cells: a bioassay-guided approach
Shin et al. Isocudraxanthone K Induces Growth Inhibition and Apoptosis in Oral Cancer Cells via Hypoxia Inducible Factor‐1α
ATE303814T1 (de) Zusammensetzung mit steoridisher östrogen wirkung ohne steigerung des brustkrebsrisikos
Hsieh et al. Autophagy inhibition enhances apoptosis induced by dioscin in huh7 cells

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties